Management Team

Globus Product Room

Globus Medical’s management team is helping drive significant technological advancements across a complete suite of spine, trauma and robotic products.

David C. Paul

Executive Chairman

David C. Paul has served as our Chief Executive Officer from our inception in 2003 until August 2017, when he transitioned into the role of Executive Chairman. Prior to founding Globus, Mr. Paul was employed at Synthes in various positions. Mr. Paul served as Director of Product Development for Synthes in his last position, where he was responsible for product development and marketing functions. Prior to Synthes, Mr. Paul worked as a Research Engineer in biomaterials research at Temple University. Mr. Paul is named inventor on approximately 225 patents and published applications.

Mr. Paul received a B.S. in Mechanical Engineering from the University of Madras, and an M.S. in Computer Integrated Mechanical Engineering Systems from Temple University. Mr. Paul also serves on the Board of Free Flow Medical, an early stage medical device company and Cross Ventures, LLC, a real estate development company.

Daniel Scavilla

President and Chief Executive Officer

Dan Scavilla has served as Globus Medical’s President and Chief Executive Officer since April 2022, leading Company’s acquisition of NuVasive, Inc. in an all-stock deal valued at $3 billion and integrating the two organizations to create the second largest spine technology company in the world with a greater than $7 billion market cap.  Dan serves on Globus Medical’s Board of Directors and is a member of the Nominating and Corporate Governance Committee. Previously, he served as Executive Vice President, Chief Commercial Officer and President, Trauma, where he scaled the Company’s manufacturing and distribution capabilities and launched the Orthopedics and Trauma business unit. Dan joined Globus Medical as Chief Financial Officer in 2015. 

Prior to joining Globus Medical, Dan spent 28 years in increasing leadership roles within Johnson & Johnson (J&J), including serving as Chief Financial Officer, Global Vice President Finance & Business Operations of J&J Vision ($4 billion annual global revenue), and as Chief Financial Officer, Worldwide Vice President Finance of Advanced Sterilization Products—J&J’s infection prevention business within its MedTech business unit—helping to capture the number one market position in Sterilization. Additional roles at J&J include financial management positions at McNeil Consumer Healthcare (Kenvue), Centocor Biologics, and Cilag Schaffhausen Operations in Switzerland (Janssen Pharmaceutical).  

Dan served on the board of directors of Impulse Dynamics, a privately held medical technology company focused on minimally invasive treatment options for heart failure patients, from November 2021 to July 2023. 

Dan received a B.S. in Finance and Organizational Behavior from LaSalle University and holds an MBA in International Management from Temple University. 

Kelly G. Huller, Esquire

Senior Vice President, General Counsel, and Corporate Secretary

Kelly Huller has been the Senior Vice President, General Counsel and Corporate Secretary since December 2018.  

Huller began her career at Globus in 2006 as its first in-house counsel when the Company had 200 employees and $50M in annual revenue with one business unit. Since 2006, she has led more than 10 mergers and acquisitions, the most recent being the Company’s acquisition of NuVasive, Inc. in an all-stock deal valued at $3 billion. In her 18 years at Globus Medical, Huller has helped create a $2B+ musculoskeletal global technology company with five business units and more than 5,000 employees.  

Huller leads the Company’s global legal department, overseeing its intellectual property, litigation and corporate legal functions supporting all regions and business units with responsibility for corporate and commercial transactions, employment law, risk management, corporate governance and securities matters.  

Prior to joining Globus, Huller was a trial attorney at Conrad O’Brien (now Clark Hill) in Philadelphia, representing public and private entities and non-profit organizations in areas of commercial, employment, products liability, and malpractice matters. She also served on the Board of Directors for Chester County Futures, a non-profit organization providing comprehensive academic, mentoring and scholarship support for motivated economically disadvantaged youth. 

Huller received a B.A  from Pennsylvania State University and earned her J.D. degree from Temple University. 

Keith Pfeil

Chief Operating Officer and Chief Financial Officer

Keith Pfeil has served as our Chief Operating Officer and Chief Financial Officer since February 2024. Pfeil leads the Company’s operations, finance, tax, pricing and contracts, internal audit, quality, information technology, investor relations, strategy and business development. In addition, he oversees the Company’s biologics business unit—Bone Bank Allografts (BBA). Pfeil helped lead the Company’s acquisition of NuVasive, Inc., and serves on the Executive Steering Committee for the integration of Globus Medical and NuVasive.  

Pfeil joined Globus as Chief Financial Officer in August 2019 after more than 15 years at CSS Industries, Inc., a publicly traded consumer products company. At CSS, he served as the Executive Vice President and Chief Financial Officer. Prior to that role, Pfeil served in various financial roles of increasing responsibility with focus areas including audit, business development, controllership, financial planning and analysis, investor relations and treasury. Prior to CSS Industries, he worked in the transaction advisory practice of Ernst & Young LLP, and prior to that, he worked in the assurance practices of KPMG LLP and Arthur Andersen LLP. 

Pfeil received a B.S. in Accounting from Elizabethtown College and an Executive MBA from Saint Joseph’s University.